D. Kaliontzi

发表

High Circulating Sclerostin is Present in Patients with Thalassemia-associated Osteoporosis and Correlates with Bone Mineral Density

S. Polyzos, E. Terpos, E. Voskaridou, 2012, Hormone and Metabolic Research.

High Circulating Levels of Sclerostin Correlate with Bone Mineral Density In Patients with Thalassemia and Osteoporosis: The Role of the Wnt Signaling In the Pathogenesis of Bone Loss In Thalassemia

E. Terpos, E. Voskaridou, D. Christoulas, 2010 .